Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer.
about
IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.Safety and efficacy of tumor-targeted interleukin 12 gene therapy in treated and non-treated, metastatic lesions.The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity.Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy.Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapyElectroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.Electroporation-mediated gene therapy.IL-12 based gene therapy in veterinary medicine.Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillanceElectrogene therapy with interleukin-12 in canine mast cell tumorsIntratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid).Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2(180-188)-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2(180-188) peptides.
P2860
Q33670036-A059E6BF-97BF-475C-91DD-E0A8246CF49CQ34791427-EC168418-6094-49DF-A0C8-BC5E49594BF7Q35073652-B2D7FF1B-6C22-48A3-92B8-1AD1E596A3B5Q35144433-EBA4C775-F99D-45A6-A161-8CC73C9363DAQ35206534-FF7DA2FE-1EA5-41AB-B9B6-38C7F4187A83Q36694876-EBD67BB8-F75B-4BBA-A611-C92950511DABQ36945857-7C37BC7B-AC52-4284-8190-6B165F8ED1C5Q38061510-B55BD38F-EBD1-4445-BBDD-9F0F3DB699ADQ38703318-AF831719-A2DD-4E3C-B335-17416CD68114Q39834167-0D39E862-9C7D-47B0-8C30-049126BB8A0EQ42284597-C14D9618-253D-4F1E-B4C5-F6E2F397D471Q45857246-61A63C95-C2D6-4BDE-A65E-00B728234C22Q45873521-DA0D6FCD-8BB6-49F7-BD8A-1490EF111FFDQ50964057-0721D7B6-ACA0-4AF2-A5C4-A4C3CB9050CF
P2860
Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Administration route- and immu ...... ation by IL12 electrotransfer.
@en
type
label
Administration route- and immu ...... ation by IL12 electrotransfer.
@en
prefLabel
Administration route- and immu ...... ation by IL12 electrotransfer.
@en
P2093
P1433
P1476
Administration route- and immu ...... ation by IL12 electrotransfer.
@en
P2093
Lijie Zhang
Marina Torrero
Martin Cannon
Robin Barret
P304
P356
10.1016/J.YMTHE.2005.03.037
P577
2005-06-13T00:00:00Z